FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2995962927> ?p ?o ?g. }

• W2995962927 endingPage "818" @default.
• W2995962927 startingPage "808" @default.
• W2995962927 abstract "PATHFx is a clinical decision-support tool based on machine learning capable of estimating the likelihood of survival after surgery for patients with skeletal metastases. The applicability of any machine-learning tool depends not only on successful external validation in unique patient populations but also on remaining relevant as more effective systemic treatments are introduced. With advancements in the treatment of metastatic disease, it is our responsibility to patients to ensure clinical support tools remain contemporary and accurate.Therefore, we sought to (1) generate updated PATHFx models using recent data from patients treated at one large, urban tertiary referral center and (2) externally validate the models using two contemporary patient populations treated either surgically or nonsurgically with external-beam radiotherapy alone for symptomatic skeletal metastases for symptomatic lesions.After obtaining institutional review board approval, we collected data on 208 patients undergoing surgical treatment for pathologic fractures at Memorial Sloan Kettering Cancer Center between 2015 and 2018. These data were combined with the original PATHFx training set (n = 189) to create the final training set (n = 397). We then created six Bayesian belief networks designed to estimate the likelihood of 1-month, 3-month, 6-month, 12-month, 18-month, and 24-month survival after treatment. Bayesian belief analysis is a statistical method that allows data-driven learning to arise from conditional probabilities by exploring relationships between variables to estimate the likelihood of an outcome using observed data. For external validation, we extracted the records of patients treated between 2016 and 2018 from the International Bone Metastasis Registry and records of patients treated nonoperatively with external-beam radiation therapy for symptomatic skeletal metastases from 2012 to 2016 using the Military Health System Data Repository (radiotherapy-only group). From each record, we collected the date of treatment, laboratory values at the time of treatment initiation, demographic data, details of diagnosis, and the date of death. All records reported sufficient follow-up to establish survival (yes/no) at 24-months after treatment. For external validation, we applied the data from each record to the new PATHFx models. We assessed calibration (calibration plots), accuracy (Brier score), discriminatory ability (area under the receiver operating characteristic curve [AUC]).The updated PATHFx version 3.0 models successfully classified survival at each time interval in both external validation sets and demonstrated appropriate discriminatory ability and model calibration. The Bayesian models were reasonably calibrated to the Memorial Sloan Kettering Cancer Center training set. External validation with 197 records from the International Bone Metastasis Registry and 192 records from the Military Health System Data Repository for analysis found Brier scores that were all less than 0.20, with upper bounds of the 95% confidence intervals all less than 0.25, both for the radiotherapy-only and International Bone Metastasis Registry groups. Additionally, AUC estimates were all greater than 0.70, with lower bounds of the 95% CI all greater than 0.68, except for the 1-month radiotherapy-only group. To complete external validation, decision curve analysis demonstrated clinical utility. This means it was better to use the PATHFx models when compared to the default assumption that all or no patients would survive at all time periods except for the 1-month models. We believe the favorable Brier scores (< 0.20) as well as DCA indicate these models are suitable for clinical use.We successfully updated PATHFx using contemporary data from patients undergoing either surgical or nonsurgical treatment for symptomatic skeletal metastases. These models have been incorporated for clinical use on PATHFx version 3.0 (https://www.pathfx.org). Clinically, external validation suggests it is better to use PATHFx version 3.0 for all time periods except when deciding whether to give radiotherapy to patients with the life expectancy of less than 1 month. This is partly because most patients survived 1-month after treatment. With the advancement of medical technology in treatment and diagnosis for patients with metastatic bone disease, part of our fiduciary responsibility is to the main current clinical support tools.Level III, therapeutic study." @default.
• W2995962927 created "2019-12-26" @default.
• W2995962927 creator A5022207361 @default.
• W2995962927 creator A5022233174 @default.
• W2995962927 creator A5030923618 @default.
• W2995962927 creator A5051653125 @default.
• W2995962927 creator A5076588912 @default.
• W2995962927 creator A5090390313 @default.
• W2995962927 date "2019-12-21" @default.
• W2995962927 modified "2023-10-11" @default.
• W2995962927 title "External Validation of PATHFx Version 3.0 in Patients Treated Surgically and Nonsurgically for Symptomatic Skeletal Metastases" @default.
• W2995962927 cites W1939342783 @default.
• W2995962927 cites W1998169483 @default.
• W2995962927 cites W2030346622 @default.
• W2995962927 cites W2032458393 @default.
• W2995962927 cites W2045030989 @default.
• W2995962927 cites W2078271269 @default.
• W2995962927 cites W2102471802 @default.
• W2995962927 cites W2157995113 @default.
• W2995962927 cites W2336798453 @default.
• W2995962927 cites W2557572013 @default.
• W2995962927 cites W2617904360 @default.
• W2995962927 cites W2893960509 @default.
• W2995962927 cites W2911420851 @default.
• W2995962927 doi "https://doi.org/10.1097/corr.0000000000001081" @default.
• W2995962927 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7282571" @default.
• W2995962927 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32195761" @default.
• W2995962927 hasPublicationYear "2019" @default.
• W2995962927 type Work @default.
• W2995962927 sameAs 2995962927 @default.
• W2995962927 citedByCount "49" @default.
• W2995962927 countsByYear W29959629272020 @default.
• W2995962927 countsByYear W29959629272021 @default.
• W2995962927 countsByYear W29959629272022 @default.
• W2995962927 countsByYear W29959629272023 @default.
• W2995962927 crossrefType "journal-article" @default.
• W2995962927 hasAuthorship W2995962927A5022207361 @default.
• W2995962927 hasAuthorship W2995962927A5022233174 @default.
• W2995962927 hasAuthorship W2995962927A5030923618 @default.
• W2995962927 hasAuthorship W2995962927A5051653125 @default.
• W2995962927 hasAuthorship W2995962927A5076588912 @default.
• W2995962927 hasAuthorship W2995962927A5090390313 @default.
• W2995962927 hasBestOaLocation W29959629271 @default.
• W2995962927 hasConcept C119857082 @default.
• W2995962927 hasConcept C126838900 @default.
• W2995962927 hasConcept C141071460 @default.
• W2995962927 hasConcept C19527891 @default.
• W2995962927 hasConcept C2776135927 @default.
• W2995962927 hasConcept C33724603 @default.
• W2995962927 hasConcept C41008148 @default.
• W2995962927 hasConcept C512399662 @default.
• W2995962927 hasConcept C71924100 @default.
• W2995962927 hasConceptScore W2995962927C119857082 @default.
• W2995962927 hasConceptScore W2995962927C126838900 @default.
• W2995962927 hasConceptScore W2995962927C141071460 @default.
• W2995962927 hasConceptScore W2995962927C19527891 @default.
• W2995962927 hasConceptScore W2995962927C2776135927 @default.
• W2995962927 hasConceptScore W2995962927C33724603 @default.
• W2995962927 hasConceptScore W2995962927C41008148 @default.
• W2995962927 hasConceptScore W2995962927C512399662 @default.
• W2995962927 hasConceptScore W2995962927C71924100 @default.
• W2995962927 hasIssue "4" @default.
• W2995962927 hasLocation W29959629271 @default.
• W2995962927 hasLocation W29959629272 @default.
• W2995962927 hasLocation W29959629273 @default.
• W2995962927 hasLocation W29959629274 @default.
• W2995962927 hasOpenAccess W2995962927 @default.
• W2995962927 hasPrimaryLocation W29959629271 @default.
• W2995962927 hasRelatedWork W1966261153 @default.
• W2995962927 hasRelatedWork W2285673348 @default.
• W2995962927 hasRelatedWork W2368434131 @default.
• W2995962927 hasRelatedWork W2371771839 @default.
• W2995962927 hasRelatedWork W2376026083 @default.
• W2995962927 hasRelatedWork W2380083969 @default.
• W2995962927 hasRelatedWork W2590224211 @default.
• W2995962927 hasRelatedWork W2619488769 @default.
• W2995962927 hasRelatedWork W3141213731 @default.
• W2995962927 hasRelatedWork W1414602831 @default.
• W2995962927 hasVolume "478" @default.
• W2995962927 isParatext "false" @default.
• W2995962927 isRetracted "false" @default.
• W2995962927 magId "2995962927" @default.
• W2995962927 workType "article" @default.